Leukemia is a group of blood cancers that start in the bone marrow, where a genetically damaged cell begins producing abnormal white blood cells that crowd out healthy ones. It is diagnosed with a blood count followed by a bone marrow test, and treated with chemotherapy, targeted drugs, immunotherapy, or stem cell transplant depending on the type. This comprehensive roundup of leukemia covers understanding the causes, symptoms, diagnosis, and treatment, so patients, families, and students can see how the pieces fit together.
Leukemia sits at the heart of hematology, the study of blood and blood-forming organs. For a deeper hub on the disease, see our leukemia guide.
What Is Leukemia?
Leukemia is a heterogeneous group of hematologic malignancies that begin in the marrow. Normally, marrow stem cells mature in an orderly way into red cells, white cells, and platelets. In leukemia, a single cell acquires mutations that let it multiply without control and, often, stop maturing.
Doctors classify leukemia by speed and by the type of blood cell involved. Acute leukemias grow quickly and are made of immature cells called blasts. Chronic leukemias grow slowly and involve more mature cells. Each can be lymphoid or myeloid.
| Type | Cell of origin | Typical age group | Pace |
|---|---|---|---|
| Acute lymphoblastic leukemia (ALL) | Lymphoid | Most common in young children; also adults | Rapid |
| Acute myeloid leukemia (AML) | Myeloid | Mostly older adults | Rapid |
| Chronic lymphocytic leukemia (CLL) | Lymphoid (mature B cells) | Older adults | Slow, often years |
| Chronic myeloid leukemia (CML) | Myeloid | Adults, usually middle age | Slow chronic phase, can progress |
Causes and Risk Factors
Every leukemia begins with changes in DNA. These may affect proto-oncogenes (genes that promote growth), tumor suppressor genes (genes that apply the brakes), or genes controlling cell maturation. Most of these mutations are acquired during life rather than inherited, and in most patients no specific cause is ever found.
Known risk factors include:
- Ionizing radiation: high-dose exposure, such as prior radiation therapy.
- Chemical exposure: long-term exposure to benzene, found in some industrial settings and tobacco smoke.
- Prior chemotherapy: some drugs used for other cancers raise later AML risk.
- Genetic conditions: Down syndrome, Fanconi anemia, and ataxia-telangiectasia increase susceptibility.
- Smoking: linked to a higher risk of AML.
- Age: AML, CLL, and CML become more common with age.
The Philadelphia chromosome, the hallmark of CML, is a good example of an acquired change. It is not inherited; it arises in a marrow cell during a person’s lifetime.
How Leukemia Develops
At a molecular level, leukemia cells escape the normal checks on growth and cell death. In CML, a swap between chromosomes 9 and 22 creates the BCR-ABL fusion gene. It produces a tyrosine kinase that is permanently switched on, pushing cells to divide and survive.
In AML, mutations in genes such as FLT3, NPM1, and IDH1/IDH2 disrupt signaling or block maturation. Researchers are also studying proteins that control how genetic messages are processed, including RNA-binding proteins, as possible future drug targets. Understanding these pathways is what allows treatment to be matched to the individual leukemia.
Signs and Symptoms
The clinical manifestations of leukemia largely reflect bone marrow failure: as leukemia cells fill the bone marrow, normal blood production falls.
- Fatigue, breathlessness, and pallor from anemia.
- Frequent or severe infections and fevers from neutropenia (low neutrophils).
- Easy bruising, nosebleeds, gum bleeding, and petechiae (tiny red spots, often on the legs) from thrombocytopenia.
- Bone or joint pain, especially in children with ALL.
- Swollen lymph nodes, enlarged spleen or liver, causing fullness under the left ribs.
- Night sweats and unexplained weight loss.
Acute leukemia usually causes symptoms over days to weeks. Chronic leukemia, especially CLL, is often found on a routine blood test in someone who feels well.
Diagnosis: How Leukemia Is Confirmed
The work-up for leukemia diagnosis follows a logical sequence. Our guide to leukemia diagnosis tests covers each in more depth.
- Complete blood count (CBC) and blood smear: may show a high or low white count, anemia, low platelets, and circulating blasts.
- Bone marrow aspiration and biopsy: confirms the diagnosis. For acute leukemia, a blast count of 20% or more of marrow cells is the usual threshold.
- Flow cytometry: identifies surface markers to separate lymphoid from myeloid disease and define subtypes.
- Cytogenetics and molecular testing: detects changes such as BCR-ABL, FLT3, or NPM1, often with next-generation sequencing.
- Additional tests as needed: lumbar puncture in ALL to check the spinal fluid, and imaging for organ involvement.
Treatment Options
Leukemia treatment is individualized by subtype, genetic findings, age, and overall health.
- Chemotherapy: the backbone for acute leukemias, given in phases (induction, consolidation, and for ALL, maintenance).
- Targeted therapy: tyrosine kinase inhibitors such as imatinib for CML and Philadelphia-positive ALL; FLT3 and IDH inhibitors for selected AML; BTK and BCL-2 inhibitors for CLL.
- Immunotherapy: antibody-based drugs and CAR-T cell therapy, mainly for relapsed or refractory B-cell ALL.
- Stem cell transplantation: offers cure for some high-risk or relapsed leukemias.
- Watchful waiting: many people with early CLL need no treatment until the disease progresses.
- Supportive care: transfusions, antibiotics, and antifungals protect patients through low-count periods.
When to See a Doctor
See a doctor promptly if you have unexplained fatigue lasting more than a couple of weeks, repeated infections, unusual bruising or bleeding, tiny red spots on the skin, persistent fevers or night sweats, or swollen glands. Most of these symptoms have common, harmless causes, but a simple blood count can quickly rule leukemia in or out.
Frequently Asked Questions
Is leukemia hereditary?
Most leukemia is not inherited. The mutations are acquired in marrow cells during life. A few inherited syndromes raise risk, and rare families carry predisposing genes, which a hematologist may test for.
Which type of leukemia is most common in children?
Acute lymphoblastic leukemia (ALL) is the most common childhood leukemia. With modern treatment protocols, most children with ALL are cured.
Can a blood test alone diagnose leukemia?
A blood count and smear can strongly suggest leukemia, but a bone marrow test with flow cytometry and genetic studies is usually needed to confirm it and choose treatment.
Is chronic leukemia less serious than acute leukemia?
Chronic leukemias progress more slowly and are often controlled for many years. They still need specialist monitoring, and some can transform into more aggressive disease.
What is the outlook for someone diagnosed with leukemia today?
Outlook varies widely by type, genetic features, age, and response to the first round of treatment. Childhood ALL and chronic-phase CML generally do very well with current therapy, while AML in older adults remains harder to treat. Your hematologist can explain what the specific test results mean for you.
Can leukemia come back after treatment?
Yes, relapse is possible, which is why follow-up blood tests continue for years after treatment ends. Doctors often track minimal residual disease, tiny amounts of leukemia detectable only with sensitive tests, to spot relapse early and adjust treatment.
